Literature DB >> 21964959

Testicular function and physical outcome in young adult males diagnosed with idiopathic 46 XY disorders of sex development during childhood.

Thomas Blanc1, Ahmed Ayedi, Alaa El-Ghoneimi, Hendy Abdoul, Yves Aigrain, Françoise Paris, Charles Sultan, Jean-Claude Carel, Juliane Léger.   

Abstract

OBJECTIVE: There are few studies of outcome in male patients with undefined 46 XY disorder of sex development (DSD). We aimed to assess testicular function and clinical characteristics after puberty in men with idiopathic 46 XY DSD. Design We conducted a University Hospital-based observational follow-up study.
METHODS: Nineteen patients with severe hypospadias associated with other signs of defective virilization, such as microphallus, cryptorchidism, and/or bifid scrotum, who were initially managed during childhood between 1988 and 1994, were evaluated at a median age of 17.6 (16.3; 17.8) years. Outcome measures included clinical findings and serum testosterone, FSH, LH, and inhibin B concentrations.
RESULTS: Testicular function was normal in only five (26%) patients. Impaired testicular function was observed in 14 (74%) patients and was partial (n=6; 32%) or total (n=8; 42%), requiring testosterone treatment for the initial (n=2) or secondary (n=6) induction of puberty. Undescended testis (unilateral n=3, bilateral n=2) was found and surgically managed only in the 14 patients with testicular impairment. Testosterone treatment in early childhood greatly increased penis length in all patients, but persistent microphallus following surgical treatment was observed at the end of puberty in most patients, with no difference between patients with and without testicular dysfunction (penis length of 68 (60; 75) vs 65 (60; 65) mm; P=0.42). Half the patients presented an adult height more than 5 cm below their target height.
CONCLUSION: Men diagnosed with idiopathic 46 XY DSD during childhood are at high risk of testicular insufficiency and persistent micropenis, and this should be taken into account during the follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 21964959     DOI: 10.1530/EJE-11-0588

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  4 in total

1.  5 α-reductase type 2 deficiency - response to dihydrotestosterone gel: correspondence.

Authors:  Iram Shabir; Eunice Marumudi; Ram Kumar; Angela Ann Joseph; Madan L Khurana; Manju Mehta; T Satish Chandra; Ariachery C Ammini
Journal:  Indian J Pediatr       Date:  2013-09-20       Impact factor: 1.967

Review 2.  Surgical management of primary severe hypospadias in children: an update focusing on penile curvature.

Authors:  Marco Castagnetti; Alaa El-Ghoneimi
Journal:  Nat Rev Urol       Date:  2022-01-17       Impact factor: 14.432

Review 3.  Possible fetal determinants of male infertility.

Authors:  Anders Juul; Kristian Almstrup; Anna-Maria Andersson; Tina K Jensen; Niels Jørgensen; Katharina M Main; Ewa Rajpert-De Meyts; Jorma Toppari; Niels E Skakkebæk
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

4.  Increased androgen-related comorbidity in adolescents and adults born with hypospadias: A population-based study.

Authors:  Lottie Phillips; Cecilia Lundholm; Ulrik Kvist; Catarina Almqvist; Agneta Nordenskjöld; Anna Skarin Nordenvall
Journal:  Andrology       Date:  2022-07-29       Impact factor: 4.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.